Market Place
Sourcing Support
BrainsWay Invests $6M In NeuroLief After FDA MDD Nod
26 Mar 2026 //
GLOBENEWSWIRE
Brainsway Invests In Axis Integrated Mental Health For Revenue
19 Mar 2026 //
GLOBENEWSWIRE
Brainsway Reports 2025 Q4 And Full-Year Financials & Operations
11 Mar 2026 //
GLOBENEWSWIRE
BrainsWay To Release 2025 Financial Results On March 11, 2026
25 Feb 2026 //
GLOBENEWSWIRE
Brainsway To Join Citi 2026 Medtech & Life Sciences Access Day
23 Feb 2026 //
GLOBENEWSWIRE
Brainsway Invests In Canadian Provider Brainstim Health Inc
19 Feb 2026 //
GLOBENEWSWIRE
BrainsWay Says Cigna Drops TMS Prior Authorization
18 Feb 2026 //
GLOBENEWSWIRE
Brainsway Announces Change In Ads-To-Ordinary Share Ratio
17 Feb 2026 //
GLOBENEWSWIRE
Highmark Drafts Coverage Policy For Brainsway`s Deep TMS
21 Jan 2026 //
GLOBENEWSWIRE
Brainsway Announces FDA Approval Of Neurolief`s ProlivRx for DMD
12 Jan 2026 //
GLOBENEWSWIRE
Brainsway Unveils First Policy For Accelerated Deep TMS Coverage
07 Jan 2026 //
GLOBENEWSWIRE
Brainsway Hosts Virtual Analyst & Investor Day On Dec 1, 2025
25 Nov 2025 //
GLOBENEWSWIRE
Brainsway Initiates First Deep TMS 360™ Trial For Alcohol Use
17 Nov 2025 //
GLOBENEWSWIRE
Brainsway Gets FDA Nod For Deep TMS In Adolescent MDD
13 Nov 2025 //
GLOBENEWSWIRE
Brainsway Releases Q3 2025 Financial Results And Highlights
11 Nov 2025 //
GLOBENEWSWIRE
BrainsWay Gets NIH Grant for Accelerated Deep TMS in AUD
04 Nov 2025 //
GLOBENEWSWIRE
Brainsway To Release Q3 2025 Financial Results On Nov 11, 2025
28 Oct 2025 //
GLOBENEWSWIRE
Brainsway Invests More In Top U.S. Mental Health Providers
27 Oct 2025 //
GLOBENEWSWIRE
BrainsWay Gets FDA Clearance for Rapid Deep TMS for MDD
16 Sep 2025 //
GLOBENEWSWIRE
BrainsWay Invests in Neurolief for Neuromodulation Market Expand
21 Aug 2025 //
GLOBENEWSWIRE
BrainsWay Buys Minority Stake in Axis Mental Health
20 Aug 2025 //
GLOBENEWSWIRE
BrainsWay Q2 2025 Financial Results and Operational Highlights
13 Aug 2025 //
GLOBENEWSWIRE
BrainsWay`s Q2 2025 Financial Results Due August 13
30 Jul 2025 //
GLOBENEWSWIRE
BrainsWay Sponsors 2 Free TMS CME Courses for Mental Health Pros
30 Jul 2025 //
GLOBENEWSWIRE
BrainsWay Reports Positive Results from Deep TMS Study on MDD
11 Jun 2025 //
GLOBENEWSWIRE
BrainsWay to Sponsor 2025 Clinical TMS Society Annual Meeting
10 Jun 2025 //
GLOBENEWSWIRE
BrainsWay Reports Q1 2025 Financial Results and Highlights
13 May 2025 //
GLOBENEWSWIRE
BrainsWay to Showcase Deep TMS at 2025 APA Annual Meeting in LA
01 May 2025 //
GLOBENEWSWIRE
BrainsWay to Report Q1 2025 Financial Results on May 13, 2025
29 Apr 2025 //
GLOBENEWSWIRE
BrainsWay Reports Q4 and Full Year 2024 Financial Results
11 Mar 2025 //
GLOBENEWSWIRE
BrainsWay To Present At Oppenheimer 35th MedTech Conference
04 Mar 2025 //
GLOBENEWSWIRE
BrainsWay to Report 2024 Financial Results on March 11, 2025
24 Feb 2025 //
GLOBENEWSWIRE
BrainsWay`s Positive Data on Deep TMS for Alcohol Use Disorder
12 Dec 2024 //
GLOBENEWSWIRE
BrainsWay Reports Feasibility Data of Pain Reduction With Deep TMS
20 Nov 2024 //
GLOBENEWSWIRE
BrainsWay Reports Q3 2024 Financial Results & Highlights
12 Nov 2024 //
GLOBENEWSWIRE
BrainsWay to Report Q3 2024 Results on Nov 12, 2024
29 Oct 2024 //
GLOBENEWSWIRE
BrainsWay Places 15 Deep TMS Systems In Taiwan And Korea
09 Oct 2024 //
GLOBENEWSWIRE
BrainsWay Announces US$20 Million Private Placement
30 Sep 2024 //
GLOBENEWSWIRE
BrainsWay Announces Significant Expansion on U.S. East Coast
16 Sep 2024 //
GLOBENEWSWIRE
Israel Ministry Clears BrainsWay Deep TMS For PTSD Treatment
10 Sep 2024 //
GLOBENEWSWIRE
BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer
29 Aug 2024 //
GLOBENEWSWIRE
BrainsWay Reports Q2 2024 Results And Operational Highlights
06 Aug 2024 //
GLOBENEWSWIRE
BrainsWay to Report Second Quarter 2024 Financial Results on August 6, 2024
23 Jul 2024 //
GLOBENEWSWIRE
BrainsWay Signs Multi-Year Distribution Agreement In Canada
17 Jun 2024 //
GLOBENEWSWIRE
BrainsWay Launches Depression Trial For Accelerated Deep TMS Therapy
10 Jun 2024 //
GLOBENEWSWIRE
BrainsWay Receives Expanded FDA Labeling to Treat Late Life Depression
03 Jun 2024 //
GLOBENEWSWIRE
BrainsWay Q1 2024 Results, Operational Highlights
08 May 2024 //
GLOBENEWSWIRE
BrainsWay Expands Deep TMS Access in Israel
17 Apr 2024 //
GLOBENEWSWIRE
BrainsWay Announces Published Review Results Highlighting Potential of Deep TMS
04 Apr 2024 //
GLOBENEWSWIRE
BrainsWay Announces Positive Results in Late-Life Depression
28 Mar 2024 //
GLOBENEWSWIRE
BrainsWay Broadens Partnership with Katie`s Way Plus
18 Mar 2024 //
GLOBENEWSWIRE
BrainsWay Reports Fourth Quarter and Full-Year 2023 Financial Results
06 Mar 2024 //
GLOBENEWSWIRE
BrainsWay to Report Fourth Quarter and Full Year 2023 Financial Results
21 Feb 2024 //
GLOBENEWSWIRE
BrainsWay Initiates Evaluation of Rotational Field Deep TMS 360 Technology
10 Jan 2024 //
GLOBENEWSWIRE
BrainsWay Highlights Expanded Deep TMS Access with Growing Western U.S. Network
19 Dec 2023 //
GLOBENEWSWIRE
BrainsWay Announces Continued Expansion of Deep TMS„¢ in South Korea
07 Dec 2023 //
BIOSPACE
Louisiana Insurer Expands Deep TMSâ„¢ Access for 1.9 Million Covered Lives
20 Nov 2023 //
GLOBENEWSWIRE
BrainsWay Reports Third Quarter 2023 Financial Results
15 Nov 2023 //
GLOBENEWSWIRE
BrainsWay to Report Third Quarter 2023 Financial Results on November 15, 2023
01 Nov 2023 //
GLOBENEWSWIRE
BrainsWay Announces Publication of Data on Accelerated Deep TMS for Depression
16 Oct 2023 //
GLOBENEWSWIRE
